Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability.
作者信息
Meloni Giovanna, Mancini Marco, Gianfelici Valentina, Martelli Maria Paola, Foa Robin, Falini Brunangelo
出版信息
Haematologica. 2009 Feb;94(2):298-300. doi: 10.3324/haematol.2008.000059.
Abstract
摘要
相似文献
1
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability.急性髓系白血病伴NPM1突变八年后的晚期复发：NPM1突变稳定性的证据
Haematologica. 2009 Feb;94(2):298-300. doi: 10.3324/haematol.2008.000059.
2
Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.伴有 NPM1 基因突变的急性髓系白血病或骨髓增生异常综合征中的相关白血病免疫表型和可测量疾病检测。
Cytometry B Clin Cytom. 2019 Jan;96(1):67-72. doi: 10.1002/cyto.b.21744. Epub 2018 Nov 12.
3
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.基于数字液滴 PCR 的移植前 NPM1 突变负担绝对定量可预测急性髓系白血病患者的复发。
Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22.
4
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?伴有核仁磷酸蛋白（NPM1）突变的急性髓系白血病：它是一个独特的实体吗？
Blood. 2011 Jan 27;117(4):1109-20. doi: 10.1182/blood-2010-08-299990. Epub 2010 Oct 28.
5
Therapy-related acute myeloid leukaemia with mutated NPM1: treatment induced or de novo in origin?伴有NPM1突变的治疗相关急性髓系白血病：起源于治疗诱导还是新发？
Leukemia. 2008 May;22(5):891-2. doi: 10.1038/leu.2008.44.
6
Postchemotherapy erythroid cannibalism in relapsed NPM1, FLT3-mutated acute myeloid leukemia.复发的NPM1、FLT3突变型急性髓系白血病化疗后红细胞吞噬现象
Int J Lab Hematol. 2021 Apr;43(2):e80-e81. doi: 10.1111/ijlh.13382. Epub 2020 Nov 3.
7
Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.伴 NPM1 基因突变的急性髓系白血病的 blast 表型和突变影响疾病生物学和结局。
Blood Adv. 2019 Nov 12;3(21):3322-3332. doi: 10.1182/bloodadvances.2019000328.
8
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.细胞质突变型核仁磷酸蛋白在原发性白血病细胞以及重症联合免疫缺陷（SCID）小鼠的NPMc+急性髓系白血病异种移植模型中是稳定的。
Haematologica. 2008 May;93(5):775-9. doi: 10.3324/haematol.12225. Epub 2008 Mar 26.
9
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).一个单突变数学模型可以解释伴有核磷蛋白（NPM1）突变的急性髓系白血病的年龄发病率。
Haematologica. 2008 Aug;93(8):1219-26. doi: 10.3324/haematol.13209. Epub 2008 Jul 4.
10
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice.携带 NPM1 突变的 AML 中的 CD34+ 细胞具有细胞质突变的核磷蛋白，并在免疫功能低下的小鼠中产生白血病。
Blood. 2010 Nov 11;116(19):3907-22. doi: 10.1182/blood-2009-08-238899. Epub 2010 Jul 15.
引用本文的文献
1
The Role of Nucleophosmin 1 () Mutation in the Diagnosis and Management of Myeloid Neoplasms.核磷蛋白1（NPM1）突变在髓系肿瘤诊断与管理中的作用
Life (Basel). 2022 Jan 13;12(1):109. doi: 10.3390/life12010109.
2
Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.核仁磷酸蛋白 1 和异柠檬酸脱氢酶 1 和 2 作为急性髓系白血病的可测量残留疾病标志物。
PLoS One. 2021 Jun 21;16(6):e0253386. doi: 10.1371/journal.pone.0253386. eCollection 2021.
3
Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia.血液系统恶性肿瘤中的核磷蛋白1（NPM1）异常以及急性髓系白血病中突变型NPM1的治疗靶点
Ther Adv Hematol. 2020 Feb 3;11:2040620719899818. doi: 10.1177/2040620719899818. eCollection 2020.
4
Minimal/Measurable Residual Disease Monitoring in -Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.伴有突变的急性髓系白血病中的微小残留病监测：临床观点和展望。
Int J Mol Sci. 2018 Nov 6;19(11):3492. doi: 10.3390/ijms19113492.
5
Pitfalls in the molecular follow up of mutant acute myeloid leukemia.突变型急性髓系白血病分子随访中的陷阱
Haematologica. 2018 Oct;103(10):e486-e488. doi: 10.3324/haematol.2018.192104. Epub 2018 Jun 14.
6
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations.采用大规模多重数字PCR对NPM1突变的急性髓系白血病患者进行微小残留病监测
J Mol Diagn. 2017 Jul;19(4):537-548. doi: 10.1016/j.jmoldx.2017.03.005. Epub 2017 May 16.
7
Examination of the FLT3 and NPM1 mutational status in patients with acute myeloid leukemia from southeastern Poland.波兰东南部急性髓系白血病患者FLT3和NPM1突变状态的检测
Arch Med Sci. 2016 Feb 1;12(1):120-8. doi: 10.5114/aoms.2015.49811. Epub 2016 Feb 2.
8
Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia.急性髓系白血病患者血浆中循环核仁磷酸蛋白突变DNA的定量检测
Int J Med Sci. 2015 Jan 1;12(1):17-22. doi: 10.7150/ijms.10144. eCollection 2015.
9
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.NPM1 突变型急性髓系白血病的小鼠模型：生物学和临床意义。
Leukemia. 2015 Feb;29(2):269-78. doi: 10.1038/leu.2014.257. Epub 2014 Sep 2.
10
Is acute myeloid leukemia a liquid tumor?急性髓系白血病是一种液体肿瘤吗？
Int J Cancer. 2013 Aug 1;133(3):534-43. doi: 10.1002/ijc.28012. Epub 2013 Feb 4.
本文引用的文献
1
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).一个单突变数学模型可以解释伴有核磷蛋白（NPM1）突变的急性髓系白血病的年龄发病率。
Haematologica. 2008 Aug;93(8):1219-26. doi: 10.3324/haematol.13209. Epub 2008 Jul 4.
2
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.细胞遗传学正常的急性髓系白血病中的突变与治疗结果
N Engl J Med. 2008 May 1;358(18):1909-18. doi: 10.1056/NEJMoa074306.
3
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.细胞质突变型核仁磷酸蛋白在原发性白血病细胞以及重症联合免疫缺陷（SCID）小鼠的NPMc+急性髓系白血病异种移植模型中是稳定的。
Haematologica. 2008 May;93(5):775-9. doi: 10.3324/haematol.12225. Epub 2008 Mar 26.
4
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.携带细胞质突变型核磷蛋白的急性髓系白血病的独特微小RNA特征
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3945-50. doi: 10.1073/pnas.0800135105. Epub 2008 Feb 28.
5
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.在一大群年轻成年急性髓系白血病患者中，FLT3内部串联重复突变水平、数量、大小以及与NPM1突变相互作用的影响。
Blood. 2008 Mar 1;111(5):2776-84. doi: 10.1182/blood-2007-08-109090. Epub 2007 Oct 23.
6
NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia.在急性髓系白血病患者的病程中，NPM1突变比FLT3突变更稳定。
Haematologica. 2007 Sep;92(9):1268-9. doi: 10.3324/haematol.11202.
7
Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).急性髓系白血病患者极晚期复发（>5年）的特征及转归
Leuk Lymphoma. 2007 Jan;48(1):65-71. doi: 10.1080/10428190601043252.
8
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.携带细胞质/突变型核仁磷酸蛋白的急性髓系白血病（NPMc+ AML）：生物学和临床特征
Blood. 2007 Feb 1;109(3):874-85. doi: 10.1182/blood-2006-07-012252. Epub 2006 Sep 28.
9
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.免疫组织化学可预测急性髓系白血病中的核磷蛋白（NPM）突变。
Blood. 2006 Sep 15;108(6):1999-2005. doi: 10.1182/blood-2006-03-007013. Epub 2006 May 23.
10
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia.急性髓系白血病诊断20年后发生的髓系肉瘤中的细胞质核仁磷酸蛋白
Lancet Oncol. 2006 Apr;7(4):350-2. doi: 10.1016/S1470-2045(06)70661-1.
Zotero 插件